# High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy

Study · id `cardio:ct-nct02534155` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02534155](<https://clinicaltrials.gov/study/NCT02534155>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02534155

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It plans to enroll 294 participants.

## Technical summary

Registry record NCT02534155. Randomized; no masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 294 participants (planned count; ClinicalTrials.gov record NCT02534155, source copy `cardio:ctgov-nct02534155-2016-09-09`, retrieved 2026-10-26)
- Start date: 2015-04 (registry gives no type) (ClinicalTrials.gov record NCT02534155, source copy `cardio:ctgov-nct02534155-2016-09-09`, retrieved 2026-10-26)
- Primary completion: 2017-09 (anticipated) (ClinicalTrials.gov record NCT02534155, source copy `cardio:ctgov-nct02534155-2016-09-09`, retrieved 2026-10-26)
- Completion: 2018-09 (anticipated) (ClinicalTrials.gov record NCT02534155, source copy `cardio:ctgov-nct02534155-2016-09-09`, retrieved 2026-10-26)
- Countries: Germany; Italy; Switzerland (ClinicalTrials.gov record NCT02534155, source copy `cardio:ctgov-nct02534155-2016-09-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02534155-2016-09-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy
- Acronym: HiRiDe
- Condition: Mitral Valve Insufficiency
- Intervention (Device): MitraClip®
- Intervention (Procedure): Mitral valve Surgery
- Lead sponsor: University of Zurich
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry intervention name matches this record: MitraClip (`cardio:mitraclip`)
- Registry lists this organization as the lead sponsor: University of Zurich (`cardio:org-university-of-zurich`)

## Provenance

Content hash: da17f06cb03abf7c940d9596b55a5a407fb03a027d57bd30c3ab7768783fab13
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
